GT BIOPHARMA INC's ticker is GTBP and the CUSIP is 36254L209. A total of 36 filers reported holding GT BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,948 | -22.7% | 8,078 | 0.0% | 0.00% | – |
| Q2 2023 | $2,520 | -43.3% | 8,078 | 0.0% | 0.00% | – |
| Q1 2023 | $4,443 | -35.8% | 8,078 | +3.4% | 0.00% | – |
| Q4 2022 | $6,918 | +38.4% | 7,811 | +119.1% | 0.00% | – |
| Q3 2022 | $5,000 | -98.8% | 3,565 | -97.3% | 0.00% | – |
| Q2 2022 | $400,000 | -47.9% | 134,043 | -49.8% | 0.00% | – |
| Q1 2022 | $768,000 | -43.1% | 266,914 | -39.7% | 0.00% | – |
| Q4 2021 | $1,350,000 | -20.6% | 442,794 | +75.5% | 0.00% | – |
| Q3 2021 | $1,701,000 | +215.0% | 252,291 | +624.1% | 0.00% | – |
| Q2 2021 | $540,000 | +2900.0% | 34,840 | +1235.9% | 0.00% | – |
| Q1 2021 | $18,000 | – | 2,608 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baskin Financial Services Inc. | 151,354 | $36 | 0.00% |
| Moss Adams Wealth Advisors LLC | 20,000 | $4,822 | 0.00% |
| UBS Group AG | 8,750 | $2,109 | 0.00% |
| Compagnie Lombard Odier SCmA | 50,000 | $12,055 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,270 | $305 | 0.00% |
| FMR LLC | 150 | $36 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 508 | $122 | 0.00% |
| WELLS FARGO & COMPANY/MN | 300,697 | $72,498 | 0.00% |
| NORTHERN TRUST CORP | 32,347 | $7,799 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |